Literature DB >> 22258063

Hypertension, dyslipidemia and overweight are related to lower testosterone levels in a cohort of men undergoing prostate biopsy.

E Garcia-Cruz1, M Piqueras, J Huguet, M Perez-Marquez, D Gosalbez, L Peri, L Izquierdo, P Luque, M J Ribal, A Alcaraz.   

Abstract

Testosterone deficiency syndrome (TDS) is a clinical and biochemical entity related to sexual and cardiovascular health. Hypertension, diabetes mellitus (DM), dyslipidemia and overweight are four clinical factors strongly related to cardiovascular illnesses. The aim of our study was to determine if the presence and number of cardiovascular risk factors was related to total testosterone levels and the presence of biochemical TDS. We retrospectively analyzed 384 patients referred to our center for prostate biopsy between September 2007 and December 2009. Variables age, height, weight, body mass index (BMI), tobacco use, alcohol intake, hypertension, DM, dyslipidemia (hypercholesterolemia/hypertriglyceridemia) and overweight (BMI>25) were recorded prospectively. Hormonal profile was determined as part of our clinical protocol. We used 231 and 346 ng dl(-1) as total testosterone cut-points (8-12 nmol l(-1)) for diagnosis of biochemical TDS, following ISA-ISSAM-EAU Guidelines. We analyzed the relationship between testosterone levels and the presence of hypertension, DM, dyslipidemia and overweight, and with the number of these cardiovascular risk factors. Mean age was 66 ± 8 years. Prevalence of TDS was 6.5% within the 231 ng ml(-1) cutoff point and 28.4% for the 346 ng dl(-1) cutoff point. Levels of testosterone were related to hypertension (P=0.007), dyslipidemia (P=0.013), overweight (P=0.036) and the number of cardiovascular risk factors (P=0.018). The prevalence of TDS in our population is comparable to data from international studies. Testosterone levels decrease as the number of cardiovascular risk factors rise.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22258063     DOI: 10.1038/ijir.2011.55

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  9 in total

1.  Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study.

Authors:  Jared W Magnani; Carlee B Moser; Joanne M Murabito; Lisa M Sullivan; Na Wang; Patrick T Ellinor; Ramachandran S Vasan; Emelia J Benjamin; Andrea D Coviello
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-03-08

2.  Vascular dysfunction and increased cardiovascular risk in hypospadias.

Authors:  Angela K Lucas-Herald; Augusto C Montezano; Rheure Alves-Lopes; Laura Haddow; Malika Alimussina; Stuart O'Toole; Martyn Flett; Boma Lee; S Basith Amjad; Mairi Steven; Katriona Brooksbank; Linsay McCallum; Christian Delles; Sandosh Padmanabhan; S Faisal Ahmed; Rhian M Touyz
Journal:  Eur Heart J       Date:  2022-05-14       Impact factor: 35.855

Review 3.  Benefits and Consequences of Testosterone Replacement Therapy: A Review.

Authors:  Polackwich As; Tadros Nn; Ostrowski Ka; Hedges Jc
Journal:  Eur Endocrinol       Date:  2013-03-15

4.  Serum 25-hydroxyvitamin D levels and testosterone deficiency in middle-aged Korean men: a cross-sectional study.

Authors:  Young Jin Tak; Jeong Gyu Lee; Yun Jin Kim; Nam Cheol Park; Sang Soo Kim; Sangyeoup Lee; Byung Mann Cho; Eun Hee Kong; Dong Wook Jung; Yu Hyeon Yi
Journal:  Asian J Androl       Date:  2015 Mar-Apr       Impact factor: 3.285

5.  Evidence from single nucleotide polymorphism analyses of ADVANCE study demonstrates EFNB3 as a hypertension risk gene.

Authors:  Johanne Tremblay; Yujia Wang; John Raelson; Francois-Christophe Marois-Blanchet; Zenghui Wu; Hongyu Luo; Edward Bradley; John Chalmers; Mark Woodward; Stephen Harrap; Pavel Hamet; Jiangping Wu
Journal:  Sci Rep       Date:  2017-03-08       Impact factor: 4.379

Review 6.  Male Obesity-related Secondary Hypogonadism - Pathophysiology, Clinical Implications and Management.

Authors:  Cornelius J Fernandez; Elias C Chacko; Joseph M Pappachan
Journal:  Eur Endocrinol       Date:  2019-08-16

7.  A Variant in the Nicotinic Acetylcholine Receptor Alpha 3 Subunit Gene Is Associated With Hypertension Risks in Hypogonadic Patients.

Authors:  Tao Wu; Yujia Wang; Wei Shi; Bi-Qi Zhang; John Raelson; Yu-Mei Yao; Huan-Dong Wu; Zao-Xian Xu; Francois-Christophe Marois-Blanchet; Jonathan Ledoux; Rikard Blunck; Jian-Zhong Sheng; Shen-Jiang Hu; Hongyu Luo; Jiangping Wu
Journal:  Front Genet       Date:  2020-11-27       Impact factor: 4.599

8.  EPHB6 and testosterone in concert regulate epinephrine release by adrenal gland chromaffin cells.

Authors:  Yujia Wang; Wei Shi; Alexandre Blanchette; Junzheng Peng; Shijie Qi; Hongyu Luo; Jonathan Ledoux; Jiangping Wu
Journal:  Sci Rep       Date:  2018-01-16       Impact factor: 4.379

9.  The association of diabetes with risk of prostate cancer defined by clinical and molecular features.

Authors:  Xiaoshuang Feng; Mingyang Song; Mark A Preston; Wenjie Ma; Yang Hu; Claire H Pernar; Konrad H Stopsack; Ericka M Ebot; Benjamin C Fu; Yiwen Zhang; Ni Li; Min Dai; Lydia Liu; Edward L Giovannucci; Lorelei A Mucci
Journal:  Br J Cancer       Date:  2020-05-29       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.